Literature DB >> 11780774

Neuroprotective effects of MK 801 and hypothermia used alone and in combination in hypoxic-ischemic brain injury in neonatal rats.

T Alkan1, N Kahveci, L Buyukuysal, E Korfali, K Ozluk.   

Abstract

Although accumulating evidence suggests that increased extracellular glutamate concentrations may play an important role in hypoxic-ischemic brain injury, dopamine and other catecholamines also seem to be involved. The N-methyl-D-aspartate receptor antagonist MK 801 and moderate hypothermia (32-34 degrees C) are each known to be neuroprotective, but their combined effect on the release and metabolism of neurotransmitters is unknown. Seven-day-old pups (n: 150) underwent right common carotid artery ligation to induce hemispheric ischemia, and were later subjected to 120 minutes of hypoxia with 8% O2 and 92% N2O. Half the rats (Group I, n: 74) were subjected to normothermic conditions throughout the hypoxic period. Moderate hypothermia (30-32 degrees C) was induced in the other pups (Group II, n: 76) immediately after artery occlusion, and was maintained throughout the hypoxic period. Prior to inducing hypoxia, half of the rats in each group (Groups IA and IIA) received vehicle solution (0.9% NaCI) and the other rats (Groups IB and IIB) received MK 801 (0.5 mg/kg) subcutaneously at 45 and 120 minutes after occlusion. Intracerebral temperature was recorded every 15 minutes after occlusion. Infarct area (n: 40) was calculated after staining with 2% 2,3,5 triphenyltetrazolium chloride. Neuronal damage (n: 42) was assessed by quantifying CA1-CA3 neuronal loss at five hippocampal levels. The amount of damage to the monoamine system of the corpus striatum was determined based on the dopamine and 3,4 dihydroxyphenylacetic acid levels in the corpus striatum in both hemispheres (n: 46), as measured by high-pressure liquid chromatography and compared with normal control pups' values (n: 10). The normothermia/saline-treated pups had significantly larger infarct areas than the MK 801 only, hypothermia only, or MK 801/hypothermia combination groups. Neuropathological examination and striatal tissue monoamine data also confirmed marked neuronal damage in this group. Although MK 801 treatment alone resulted in significantly smaller infarct area and less tissue damage than was observed in the normothermia/saline-treated group, the moderate hypothermia and the MK 801/hypothermia combination treatment groups both exhibited better neuronal protection, especially in the corpus striatum. The rats that received combined treatment also had a significantly lower mortality rate.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11780774     DOI: 10.1076/apab.109.2.135.4271

Source DB:  PubMed          Journal:  Arch Physiol Biochem        ISSN: 1381-3455            Impact factor:   4.076


  11 in total

Review 1.  Neuroprotection Strategies for Term Encephalopathy.

Authors:  Fernando F Gonzalez
Journal:  Semin Pediatr Neurol       Date:  2019-08-07       Impact factor: 1.636

Review 2.  Therapeutic Hypothermia and Neuroprotection in Acute Neurological Disease.

Authors:  Kota Kurisu; Jong Youl Kim; Jesung You; Midori A Yenari
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

Review 3.  Neuroprotection in the newborn infant.

Authors:  Fernando F Gonzalez; Donna M Ferriero
Journal:  Clin Perinatol       Date:  2009-12       Impact factor: 3.430

Review 4.  Hypothermic neuroprotection.

Authors:  A J Gunn; M Thoresen
Journal:  NeuroRx       Date:  2006-04

5.  Glibenclamide improves neurological function in neonatal hypoxia-ischemia in rats.

Authors:  Yilin Zhou; Nancy Fathali; Tim Lekic; Jiping Tang; John H Zhang
Journal:  Brain Res       Date:  2009-03-21       Impact factor: 3.252

6.  Combination of therapeutic hypothermia and other neuroprotective strategies after an ischemic cerebral insult.

Authors:  Joline Goossens; Saïd Hachimi-Idrissi
Journal:  Curr Neuropharmacol       Date:  2014-09       Impact factor: 7.363

7.  Combination of mild hypothermia with neuroprotectants has greater neuroprotective effects during oxygen-glucose deprivation and reoxygenation-mediated neuronal injury.

Authors:  Xiao-Ya Gao; Jian-Ou Huang; Ya-Fang Hu; Yong Gu; Shu-Zhen Zhu; Kai-Bin Huang; Jin-Yu Chen; Su-Yue Pan
Journal:  Sci Rep       Date:  2014-11-18       Impact factor: 4.379

Review 8.  Targeting Sentinel Proteins and Extrasynaptic Glutamate Receptors: a Therapeutic Strategy for Preventing the Effects Elicited by Perinatal Asphyxia?

Authors:  Mario Herrera-Marschitz; Ronald Perez-Lobos; Carolyne Lespay-Rebolledo; Andrea Tapia-Bustos; Emmanuel Casanova-Ortiz; Paola Morales; Jose-Luis Valdes; Diego Bustamante; Bruce K Cassels
Journal:  Neurotox Res       Date:  2017-08-26       Impact factor: 3.911

9.  Hypothermia but not NMDA receptor antagonism protects against stroke induced by distal middle cerebral arterial occlusion in mice.

Authors:  Che-Wei Liu; Kate Hsiurong Liao; Hsin Tseng; Ching Mei Wu; Hsiao-Yun Chen; Ted Weita Lai
Journal:  PLoS One       Date:  2020-03-03       Impact factor: 3.240

10.  Neuroprotective effects of quetiapine on neuronal apoptosis following experimental transient focal cerebral ischemia in rats.

Authors:  Muhammet Bahadır Yılmaz; Mehmet Tönge; Hakan Emmez; Figen Kaymaz; Memduh Kaymaz
Journal:  J Korean Neurosurg Soc       Date:  2013-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.